APO Research
Talk to an analyst

APO RESEARCH · REPORT

COX-2 Selective NSAIDs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global COX-2 Selective NSAIDs Market Analysis and Forecast 2026-2032

29 December 2025198 pages

Choose your research edition.

Industry ResearchCOX-2 Selective NSAIDs Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal COX-2 Selective NSAIDs Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal COX-2 Selective NSAIDs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal COX-2 Selective NSAIDs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal COX-2 Selective NSAIDs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global COX-2 Selective NSAIDs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for COX-2 Selective NSAIDs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for COX-2 Selective NSAIDs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for COX-2 Selective NSAIDs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for COX-2 Selective NSAIDs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of COX-2 Selective NSAIDs include Teva, Merck, Mylan, Jiangsu Hengrui Medicine, Pfizer, Lupin and Apotex, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for COX-2 Selective NSAIDs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of COX-2 Selective NSAIDs, also provides the sales of main regions and countries. Of the upcoming market potential for COX-2 Selective NSAIDs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the COX-2 Selective NSAIDs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global COX-2 Selective NSAIDs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for COX-2 Selective NSAIDs sales, projected growth trends, production technology, application and end-user industry.

COX-2 Selective NSAIDs Segment by Company

Teva

Merck

Mylan

Jiangsu Hengrui Medicine

Pfizer

Lupin

Apotex

COX-2 Selective NSAIDs Segment by Type

Valdecoxib

Rofecoxib

Celecoxib

Etoricoxib

COX-2 Selective NSAIDs Segment by Application

Hospital

Clinic

Other

COX-2 Selective NSAIDs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global COX-2 Selective NSAIDs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of COX-2 Selective NSAIDs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of COX-2 Selective NSAIDs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of COX-2 Selective NSAIDs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of COX-2 Selective NSAIDs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, COX-2 Selective NSAIDs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global COX-2 Selective NSAIDs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Valdecoxib Major Manufacturers Table 3. Rofecoxib Major Manufacturers Table 4. Celecoxib Major Manufacturers Table 5. Etoricoxib Major Manufacturers Table 6. Global COX-2 Selective NSAIDs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Other Major Manufacturers Table 10. COX-2 Selective NSAIDs Industry Trends Table 11. COX-2 Selective NSAIDs Industry Drivers Table 12. COX-2 Selective NSAIDs Industry Opportunities and Challenges Table 13. COX-2 Selective NSAIDs Industry Restraints Table 14. Global COX-2 Selective NSAIDs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global COX-2 Selective NSAIDs Revenue by Region (2021-2026) & (US$ Million) Table 16. Global COX-2 Selective NSAIDs Revenue by Region (2027-2032) & (US$ Million) Table 17. Global COX-2 Selective NSAIDs Revenue Market Share by Region (2021-2026) Table 18. Global COX-2 Selective NSAIDs Revenue Market Share by Region (2027-2032) Table 19. Global COX-2 Selective NSAIDs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global COX-2 Selective NSAIDs Sales by Region (2021-2026) & (K Units) Table 21. Global COX-2 Selective NSAIDs Sales by Region (2027-2032) & (K Units) Table 22. Global COX-2 Selective NSAIDs Sales Market Share by Region (2021-2026) Table 23. Global COX-2 Selective NSAIDs Sales Market Share by Region (2027-2032) Table 24. Global COX-2 Selective NSAIDs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global COX-2 Selective NSAIDs Revenue Market Share by Manufacturers (2021-2026) Table 26. Global COX-2 Selective NSAIDs Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global COX-2 Selective NSAIDs Sales Market Share by Manufacturers (2021-2026) Table 28. Global COX-2 Selective NSAIDs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global COX-2 Selective NSAIDs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global COX-2 Selective NSAIDs Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global COX-2 Selective NSAIDs Manufacturers, Product Type & Application Table 32. Global COX-2 Selective NSAIDs Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global COX-2 Selective NSAIDs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global COX-2 Selective NSAIDs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global COX-2 Selective NSAIDs Revenue by Type (2021-2026) & (US$ Million) Table 37. Global COX-2 Selective NSAIDs Revenue by Type (2027-2032) & (US$ Million) Table 38. Global COX-2 Selective NSAIDs Revenue Market Share by Type (2021-2026) Table 39. Global COX-2 Selective NSAIDs Revenue Market Share by Type (2027-2032) Table 40. Global COX-2 Selective NSAIDs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units) Table 42. Global COX-2 Selective NSAIDs Sales by Type (2027-2032) & (K Units) Table 43. Global COX-2 Selective NSAIDs Sales Market Share by Type (2021-2026) Table 44. Global COX-2 Selective NSAIDs Sales Market Share by Type (2027-2032) Table 45. Global COX-2 Selective NSAIDs Price by Type (2021-2026) & (US$/Unit) Table 46. Global COX-2 Selective NSAIDs Price by Type (2027-2032) & (US$/Unit) Table 47. Global COX-2 Selective NSAIDs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global COX-2 Selective NSAIDs Revenue by Application (2021-2026) & (US$ Million) Table 49. Global COX-2 Selective NSAIDs Revenue by Application (2027-2032) & (US$ Million) Table 50. Global COX-2 Selective NSAIDs Revenue Market Share by Application (2021-2026) Table 51. Global COX-2 Selective NSAIDs Revenue Market Share by Application (2027-2032) Table 52. Global COX-2 Selective NSAIDs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units) Table 54. Global COX-2 Selective NSAIDs Sales by Application (2027-2032) & (K Units) Table 55. Global COX-2 Selective NSAIDs Sales Market Share by Application (2021-2026) Table 56. Global COX-2 Selective NSAIDs Sales Market Share by Application (2027-2032) Table 57. Global COX-2 Selective NSAIDs Price by Application (2021-2026) & (US$/Unit) Table 58. Global COX-2 Selective NSAIDs Price by Application (2027-2032) & (US$/Unit) Table 59. Teva Company Information Table 60. Teva Business Overview Table 61. Teva COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Teva COX-2 Selective NSAIDs Product Portfolio Table 63. Teva Recent Development Table 64. Merck Company Information Table 65. Merck Business Overview Table 66. Merck COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Merck COX-2 Selective NSAIDs Product Portfolio Table 68. Merck Recent Development Table 69. Mylan Company Information Table 70. Mylan Business Overview Table 71. Mylan COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Mylan COX-2 Selective NSAIDs Product Portfolio Table 73. Mylan Recent Development Table 74. Jiangsu Hengrui Medicine Company Information Table 75. Jiangsu Hengrui Medicine Business Overview Table 76. Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Product Portfolio Table 78. Jiangsu Hengrui Medicine Recent Development Table 79. Pfizer Company Information Table 80. Pfizer Business Overview Table 81. Pfizer COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Pfizer COX-2 Selective NSAIDs Product Portfolio Table 83. Pfizer Recent Development Table 84. Lupin Company Information Table 85. Lupin Business Overview Table 86. Lupin COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Lupin COX-2 Selective NSAIDs Product Portfolio Table 88. Lupin Recent Development Table 89. Apotex Company Information Table 90. Apotex Business Overview Table 91. Apotex COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Apotex COX-2 Selective NSAIDs Product Portfolio Table 93. Apotex Recent Development Table 94. North America COX-2 Selective NSAIDs Revenue by Type (2021-2026) & (US$ Million) Table 95. North America COX-2 Selective NSAIDs Revenue by Type (2027-2032) & (US$ Million) Table 96. North America COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units) Table 97. North America COX-2 Selective NSAIDs Sales by Type (2027-2032) & (K Units) Table 98. North America COX-2 Selective NSAIDs Sales Price by Type (2021-2026) & (US$/Unit) Table 99. North America COX-2 Selective NSAIDs Sales Price by Type (2027-2032) & (US$/Unit) Table 100. North America COX-2 Selective NSAIDs Revenue by Application (2021-2026) & (US$ Million) Table 101. North America COX-2 Selective NSAIDs Revenue by Application (2027-2032) & (US$ Million) Table 102. North America COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units) Table 103. North America COX-2 Selective NSAIDs Sales by Application (2027-2032) & (K Units) Table 104. North America COX-2 Selective NSAIDs Sales Price by Application (2021-2026) & (US$/Unit) Table 105. North America COX-2 Selective NSAIDs Sales Price by Application (2027-2032) & (US$/Unit) Table 106. North America COX-2 Selective NSAIDs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. North America COX-2 Selective NSAIDs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 108. North America COX-2 Selective NSAIDs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 109. North America COX-2 Selective NSAIDs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 110. North America COX-2 Selective NSAIDs Sales by Country (2021-2026) & (K Units) Table 111. North America COX-2 Selective NSAIDs Sales by Country (2027-2032) & (K Units) Table 112. North America COX-2 Selective NSAIDs Sales Price by Country (2021-2026) & (US$/Unit) Table 113. North America COX-2 Selective NSAIDs Sales Price by Country (2027-2032) & (US$/Unit) Table 114. United States COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 115. Canada COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 116. Mexico COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 117. Europe COX-2 Selective NSAIDs Revenue by Type (2021-2026) & (US$ Million) Table 118. Europe COX-2 Selective NSAIDs Revenue by Type (2027-2032) & (US$ Million) Table 119. Europe COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units) Table 120. Europe COX-2 Selective NSAIDs Sales by Type (2027-2032) & (K Units) Table 121. Europe COX-2 Selective NSAIDs Sales Price by Type (2021-2026) & (US$/Unit) Table 122. Europe COX-2 Selective NSAIDs Sales Price by Type (2027-2032) & (US$/Unit) Table 123. Europe COX-2 Selective NSAIDs Revenue by Application (2021-2026) & (US$ Million) Table 124. Europe COX-2 Selective NSAIDs Revenue by Application (2027-2032) & (US$ Million) Table 125. Europe COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units) Table 126. Europe COX-2 Selective NSAIDs Sales by Application (2027-2032) & (K Units) Table 127. Europe COX-2 Selective NSAIDs Sales Price by Application (2021-2026) & (US$/Unit) Table 128. Europe COX-2 Selective NSAIDs Sales Price by Application (2027-2032) & (US$/Unit) Table 129. Europe COX-2 Selective NSAIDs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Europe COX-2 Selective NSAIDs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. Europe COX-2 Selective NSAIDs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. Europe COX-2 Selective NSAIDs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 133. Europe COX-2 Selective NSAIDs Sales by Country (2021-2026) & (K Units) Table 134. Europe COX-2 Selective NSAIDs Sales by Country (2027-2032) & (K Units) Table 135. Europe COX-2 Selective NSAIDs Sales Price by Country (2021-2026) & (US$/Unit) Table 136. Europe COX-2 Selective NSAIDs Sales Price by Country (2027-2032) & (US$/Unit) Table 137. Germany COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 138. France COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 139. U.K. COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 140. Italy COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 141. Russia COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 142. Spain COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 143. Netherlands COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 144. Switzerland COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 145. Sweden COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 146. Poland COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 147. China COX-2 Selective NSAIDs Revenue by Type (2021-2026) & (US$ Million) Table 148. China COX-2 Selective NSAIDs Revenue by Type (2027-2032) & (US$ Million) Table 149. China COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units) Table 150. China COX-2 Selective NSAIDs Sales by Type (2027-2032) & (K Units) Table 151. China COX-2 Selective NSAIDs Sales Price by Type (2021-2026) & (US$/Unit) Table 152. China COX-2 Selective NSAIDs Sales Price by Type (2027-2032) & (US$/Unit) Table 153. China COX-2 Selective NSAIDs Revenue by Application (2021-2026) & (US$ Million) Table 154. China COX-2 Selective NSAIDs Revenue by Application (2027-2032) & (US$ Million) Table 155. China COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units) Table 156. China COX-2 Selective NSAIDs Sales by Application (2027-2032) & (K Units) Table 157. China COX-2 Selective NSAIDs Sales Price by Application (2021-2026) & (US$/Unit) Table 158. China COX-2 Selective NSAIDs Sales Price by Application (2027-2032) & (US$/Unit) Table 159. Asia COX-2 Selective NSAIDs Revenue by Type (2021-2026) & (US$ Million) Table 160. Asia COX-2 Selective NSAIDs Revenue by Type (2027-2032) & (US$ Million) Table 161. Asia COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units) Table 162. Asia COX-2 Selective NSAIDs Sales by Type (2027-2032) & (K Units) Table 163. Asia COX-2 Selective NSAIDs Sales Price by Type (2021-2026) & (US$/Unit) Table 164. Asia COX-2 Selective NSAIDs Sales Price by Type (2027-2032) & (US$/Unit) Table 165. Asia COX-2 Selective NSAIDs Revenue by Application (2021-2026) & (US$ Million) Table 166. Asia COX-2 Selective NSAIDs Revenue by Application (2027-2032) & (US$ Million) Table 167. Asia COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units) Table 168. Asia COX-2 Selective NSAIDs Sales by Application (2027-2032) & (K Units) Table 169. Asia COX-2 Selective NSAIDs Sales Price by Application (2021-2026) & (US$/Unit) Table 170. Asia COX-2 Selective NSAIDs Sales Price by Application (2027-2032) & (US$/Unit) Table 171. Asia COX-2 Selective NSAIDs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. Asia COX-2 Selective NSAIDs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. Asia COX-2 Selective NSAIDs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. Asia COX-2 Selective NSAIDs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 175. Asia COX-2 Selective NSAIDs Sales by Country (2021-2026) & (K Units) Table 176. Asia COX-2 Selective NSAIDs Sales by Country (2027-2032) & (K Units) Table 177. Asia COX-2 Selective NSAIDs Sales Price by Country (2021-2026) & (US$/Unit) Table 178. Asia COX-2 Selective NSAIDs Sales Price by Country (2027-2032) & (US$/Unit) Table 179. Japan COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 180. South Korea COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 181. India COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 182. Australia COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 183. Taiwan COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 184. Southeast Asia COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 185. SAMEA COX-2 Selective NSAIDs Revenue by Type (2021-2026) & (US$ Million) Table 186. SAMEA COX-2 Selective NSAIDs Revenue by Type (2027-2032) & (US$ Million) Table 187. SAMEA COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units) Table 188. SAMEA COX-2 Selective NSAIDs Sales by Type (2027-2032) & (K Units) Table 189. SAMEA COX-2 Selective NSAIDs Sales Price by Type (2021-2026) & (US$/Unit) Table 190. SAMEA COX-2 Selective NSAIDs Sales Price by Type (2027-2032) & (US$/Unit) Table 191. SAMEA COX-2 Selective NSAIDs Revenue by Application (2021-2026) & (US$ Million) Table 192. SAMEA COX-2 Selective NSAIDs Revenue by Application (2027-2032) & (US$ Million) Table 193. SAMEA COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units) Table 194. SAMEA COX-2 Selective NSAIDs Sales by Application (2027-2032) & (K Units) Table 195. SAMEA COX-2 Selective NSAIDs Sales Price by Application (2021-2026) & (US$/Unit) Table 196. SAMEA COX-2 Selective NSAIDs Sales Price by Application (2027-2032) & (US$/Unit) Table 197. SAMEA COX-2 Selective NSAIDs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 198. SAMEA COX-2 Selective NSAIDs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 199. SAMEA COX-2 Selective NSAIDs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 200. SAMEA COX-2 Selective NSAIDs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 201. SAMEA COX-2 Selective NSAIDs Sales by Country (2021-2026) & (K Units) Table 202. SAMEA COX-2 Selective NSAIDs Sales by Country (2027-2032) & (K Units) Table 203. SAMEA COX-2 Selective NSAIDs Sales Price by Country (2021-2026) & (US$/Unit) Table 204. SAMEA COX-2 Selective NSAIDs Sales Price by Country (2027-2032) & (US$/Unit) Table 205. Brazil COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 206. Argentina COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 207. Chile COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 208. Colombia COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 209. Peru COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 210. Saudi Arabia COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 211. Israel COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 212. UAE COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 213. Turkey COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 214. Iran COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 215. Egypt COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. COX-2 Selective NSAIDs Distributors List Table 219. COX-2 Selective NSAIDs Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. COX-2 Selective NSAIDs Image Figure 2. Global COX-2 Selective NSAIDs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global COX-2 Selective NSAIDs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Valdecoxib Image Figure 5. Rofecoxib Image Figure 6. Celecoxib Image Figure 7. Etoricoxib Image Figure 8. Global COX-2 Selective NSAIDs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global COX-2 Selective NSAIDs Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Other Image Figure 13. Global COX-2 Selective NSAIDs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global COX-2 Selective NSAIDs Revenue (2021-2032) & (US$ Million) Figure 15. Global COX-2 Selective NSAIDs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global COX-2 Selective NSAIDs Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global COX-2 Selective NSAIDs Revenue Market Share by Region (2021-2032) Figure 18. Global COX-2 Selective NSAIDs Sales (2021-2032) & (K Units) Figure 19. Global COX-2 Selective NSAIDs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global COX-2 Selective NSAIDs Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico COX-2 Selective NSAIDs Sales YoY (2021-2032) & (K Units) Figure 22. Europe COX-2 Selective NSAIDs Sales YoY (2021-2032) & (K Units) Figure 23. China COX-2 Selective NSAIDs Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) COX-2 Selective NSAIDs Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa COX-2 Selective NSAIDs Sales YoY (2021-2032) & (K Units) Figure 26. Global COX-2 Selective NSAIDs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global COX-2 Selective NSAIDs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global COX-2 Selective NSAIDs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global COX-2 Selective NSAIDs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global COX-2 Selective NSAIDs Revenue Market Share by Type (2021-2032) Figure 32. Global COX-2 Selective NSAIDs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global COX-2 Selective NSAIDs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global COX-2 Selective NSAIDs Sales Market Share by Type (2021-2032) Figure 35. Global COX-2 Selective NSAIDs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global COX-2 Selective NSAIDs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global COX-2 Selective NSAIDs Revenue Market Share by Application (2021-2032) Figure 38. Global COX-2 Selective NSAIDs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global COX-2 Selective NSAIDs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global COX-2 Selective NSAIDs Sales Market Share by Application (2021-2032) Figure 41. North America COX-2 Selective NSAIDs Revenue Share by Type (2021-2032) Figure 42. North America COX-2 Selective NSAIDs Sales Share by Type (2021-2032) Figure 43. North America COX-2 Selective NSAIDs Revenue Share by Application (2021-2032) Figure 44. North America COX-2 Selective NSAIDs Sales Share by Application (2021-2032) Figure 45. North America COX-2 Selective NSAIDs Revenue Share by Country (2021-2032) Figure 46. North America COX-2 Selective NSAIDs Sales Share by Country (2021-2032) Figure 47. Europe COX-2 Selective NSAIDs Revenue Share by Type (2021-2032) Figure 48. Europe COX-2 Selective NSAIDs Sales Share by Type (2021-2032) Figure 49. Europe COX-2 Selective NSAIDs Revenue Share by Application (2021-2032) Figure 50. Europe COX-2 Selective NSAIDs Sales Share by Application (2021-2032) Figure 51. Europe COX-2 Selective NSAIDs Revenue Share by Country (2021-2032) Figure 52. Europe COX-2 Selective NSAIDs Sales Share by Country (2021-2032) Figure 53. China COX-2 Selective NSAIDs Revenue Share by Type (2021-2032) Figure 54. China COX-2 Selective NSAIDs Sales Share by Type (2021-2032) Figure 55. China COX-2 Selective NSAIDs Revenue Share by Application (2021-2032) Figure 56. China COX-2 Selective NSAIDs Sales Share by Application (2021-2032) Figure 57. Asia COX-2 Selective NSAIDs Revenue Share by Type (2021-2032) Figure 58. Asia COX-2 Selective NSAIDs Sales Share by Type (2021-2032) Figure 59. Asia COX-2 Selective NSAIDs Revenue Share by Application (2021-2032) Figure 60. Asia COX-2 Selective NSAIDs Sales Share by Application (2021-2032) Figure 61. Asia COX-2 Selective NSAIDs Revenue Share by Country (2021-2032) Figure 62. Asia COX-2 Selective NSAIDs Sales Share by Country (2021-2032) Figure 63. SAMEA COX-2 Selective NSAIDs Revenue Share by Type (2021-2032) Figure 64. SAMEA COX-2 Selective NSAIDs Sales Share by Type (2021-2032) Figure 65. SAMEA COX-2 Selective NSAIDs Revenue Share by Application (2021-2032) Figure 66. SAMEA COX-2 Selective NSAIDs Sales Share by Application (2021-2032) Figure 67. SAMEA COX-2 Selective NSAIDs Revenue Share by Country (2021-2032) Figure 68. SAMEA COX-2 Selective NSAIDs Sales Share by Country (2021-2032) Figure 69. COX-2 Selective NSAIDs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. COX-2 Selective NSAIDs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Valdecoxib
  • Rofecoxib
  • Celecoxib
  • Etoricoxib
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Teva
  • Merck
  • Mylan
  • Jiangsu Hengrui Medicine
  • Pfizer
  • Lupin
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 COX-2 Selective NSAIDs Market by Type
  3. 1.2.1 Global COX-2 Selective NSAIDs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Valdecoxib
  5. 1.2.3 Rofecoxib
  6. 1.2.4 Celecoxib
  7. 1.2.5 Etoricoxib
  8. 1.3 COX-2 Selective NSAIDs Market by Application
  9. 1.3.1 Global COX-2 Selective NSAIDs Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 COX-2 Selective NSAIDs Market Dynamics
  1. 2.1 COX-2 Selective NSAIDs Industry Trends
  2. 2.2 COX-2 Selective NSAIDs Industry Drivers
  3. 2.3 COX-2 Selective NSAIDs Industry Opportunities and Challenges
  4. 2.4 COX-2 Selective NSAIDs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global COX-2 Selective NSAIDs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global COX-2 Selective NSAIDs Revenue by Region
  3. 3.2.1 Global COX-2 Selective NSAIDs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global COX-2 Selective NSAIDs Revenue by Region (2021-2026)
  5. 3.2.3 Global COX-2 Selective NSAIDs Revenue by Region (2027-2032)
  6. 3.2.4 Global COX-2 Selective NSAIDs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global COX-2 Selective NSAIDs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global COX-2 Selective NSAIDs Sales by Region
  9. 3.4.1 Global COX-2 Selective NSAIDs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global COX-2 Selective NSAIDs Sales by Region (2021-2026)
  11. 3.4.3 Global COX-2 Selective NSAIDs Sales by Region (2027-2032)
  12. 3.4.4 Global COX-2 Selective NSAIDs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global COX-2 Selective NSAIDs Revenue by Manufacturers
  2. 4.1.1 Global COX-2 Selective NSAIDs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global COX-2 Selective NSAIDs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global COX-2 Selective NSAIDs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global COX-2 Selective NSAIDs Sales by Manufacturers
  6. 4.2.1 Global COX-2 Selective NSAIDs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global COX-2 Selective NSAIDs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global COX-2 Selective NSAIDs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global COX-2 Selective NSAIDs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global COX-2 Selective NSAIDs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global COX-2 Selective NSAIDs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global COX-2 Selective NSAIDs Manufacturers, Product Type & Application
  13. 4.7 Global COX-2 Selective NSAIDs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global COX-2 Selective NSAIDs Market CR5 and HHI
  16. 4.8.2 2025 COX-2 Selective NSAIDs Tier 1, Tier 2, and Tier 3
5 COX-2 Selective NSAIDs Market by Type
  1. 5.1 Global COX-2 Selective NSAIDs Revenue by Type
  2. 5.1.1 Global COX-2 Selective NSAIDs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global COX-2 Selective NSAIDs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global COX-2 Selective NSAIDs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global COX-2 Selective NSAIDs Sales by Type
  6. 5.2.1 Global COX-2 Selective NSAIDs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global COX-2 Selective NSAIDs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global COX-2 Selective NSAIDs Sales Market Share by Type (2021-2032)
  9. 5.3 Global COX-2 Selective NSAIDs Price by Type
6 COX-2 Selective NSAIDs Market by Application
  1. 6.1 Global COX-2 Selective NSAIDs Revenue by Application
  2. 6.1.1 Global COX-2 Selective NSAIDs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global COX-2 Selective NSAIDs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global COX-2 Selective NSAIDs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global COX-2 Selective NSAIDs Sales by Application
  6. 6.2.1 Global COX-2 Selective NSAIDs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global COX-2 Selective NSAIDs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global COX-2 Selective NSAIDs Sales Market Share by Application (2021-2032)
  9. 6.3 Global COX-2 Selective NSAIDs Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva COX-2 Selective NSAIDs Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck COX-2 Selective NSAIDs Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Mylan
  14. 7.3.1 Mylan Company Information
  15. 7.3.2 Mylan Business Overview
  16. 7.3.3 Mylan COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mylan COX-2 Selective NSAIDs Product Portfolio
  18. 7.3.5 Mylan Recent Developments
  19. 7.4 Jiangsu Hengrui Medicine
  20. 7.4.1 Jiangsu Hengrui Medicine Company Information
  21. 7.4.2 Jiangsu Hengrui Medicine Business Overview
  22. 7.4.3 Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Product Portfolio
  24. 7.4.5 Jiangsu Hengrui Medicine Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer COX-2 Selective NSAIDs Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 Lupin
  32. 7.6.1 Lupin Company Information
  33. 7.6.2 Lupin Business Overview
  34. 7.6.3 Lupin COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Lupin COX-2 Selective NSAIDs Product Portfolio
  36. 7.6.5 Lupin Recent Developments
  37. 7.7 Apotex
  38. 7.7.1 Apotex Company Information
  39. 7.7.2 Apotex Business Overview
  40. 7.7.3 Apotex COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Apotex COX-2 Selective NSAIDs Product Portfolio
  42. 7.7.5 Apotex Recent Developments
8 North America
  1. 8.1 North America COX-2 Selective NSAIDs Market Size by Type
  2. 8.1.1 North America COX-2 Selective NSAIDs Revenue by Type (2021-2032)
  3. 8.1.2 North America COX-2 Selective NSAIDs Sales by Type (2021-2032)
  4. 8.1.3 North America COX-2 Selective NSAIDs Price by Type (2021-2032)
  5. 8.2 North America COX-2 Selective NSAIDs Market Size by Application
  6. 8.2.1 North America COX-2 Selective NSAIDs Revenue by Application (2021-2032)
  7. 8.2.2 North America COX-2 Selective NSAIDs Sales by Application (2021-2032)
  8. 8.2.3 North America COX-2 Selective NSAIDs Price by Application (2021-2032)
  9. 8.3 North America COX-2 Selective NSAIDs Market Size by Country
  10. 8.3.1 North America COX-2 Selective NSAIDs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America COX-2 Selective NSAIDs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America COX-2 Selective NSAIDs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe COX-2 Selective NSAIDs Market Size by Type
  2. 9.1.1 Europe COX-2 Selective NSAIDs Revenue by Type (2021-2032)
  3. 9.1.2 Europe COX-2 Selective NSAIDs Sales by Type (2021-2032)
  4. 9.1.3 Europe COX-2 Selective NSAIDs Price by Type (2021-2032)
  5. 9.2 Europe COX-2 Selective NSAIDs Market Size by Application
  6. 9.2.1 Europe COX-2 Selective NSAIDs Revenue by Application (2021-2032)
  7. 9.2.2 Europe COX-2 Selective NSAIDs Sales by Application (2021-2032)
  8. 9.2.3 Europe COX-2 Selective NSAIDs Price by Application (2021-2032)
  9. 9.3 Europe COX-2 Selective NSAIDs Market Size by Country
  10. 9.3.1 Europe COX-2 Selective NSAIDs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe COX-2 Selective NSAIDs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe COX-2 Selective NSAIDs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China COX-2 Selective NSAIDs Market Size by Type
  2. 10.1.1 China COX-2 Selective NSAIDs Revenue by Type (2021-2032)
  3. 10.1.2 China COX-2 Selective NSAIDs Sales by Type (2021-2032)
  4. 10.1.3 China COX-2 Selective NSAIDs Price by Type (2021-2032)
  5. 10.2 China COX-2 Selective NSAIDs Market Size by Application
  6. 10.2.1 China COX-2 Selective NSAIDs Revenue by Application (2021-2032)
  7. 10.2.2 China COX-2 Selective NSAIDs Sales by Application (2021-2032)
  8. 10.2.3 China COX-2 Selective NSAIDs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia COX-2 Selective NSAIDs Market Size by Type
  2. 11.1.1 Asia COX-2 Selective NSAIDs Revenue by Type (2021-2032)
  3. 11.1.2 Asia COX-2 Selective NSAIDs Sales by Type (2021-2032)
  4. 11.1.3 Asia COX-2 Selective NSAIDs Price by Type (2021-2032)
  5. 11.2 Asia COX-2 Selective NSAIDs Market Size by Application
  6. 11.2.1 Asia COX-2 Selective NSAIDs Revenue by Application (2021-2032)
  7. 11.2.2 Asia COX-2 Selective NSAIDs Sales by Application (2021-2032)
  8. 11.2.3 Asia COX-2 Selective NSAIDs Price by Application (2021-2032)
  9. 11.3 Asia COX-2 Selective NSAIDs Market Size by Country
  10. 11.3.1 Asia COX-2 Selective NSAIDs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia COX-2 Selective NSAIDs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia COX-2 Selective NSAIDs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA COX-2 Selective NSAIDs Market Size by Type
  2. 12.1.1 SAMEA COX-2 Selective NSAIDs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA COX-2 Selective NSAIDs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA COX-2 Selective NSAIDs Price by Type (2021-2032)
  5. 12.2 SAMEA COX-2 Selective NSAIDs Market Size by Application
  6. 12.2.1 SAMEA COX-2 Selective NSAIDs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA COX-2 Selective NSAIDs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA COX-2 Selective NSAIDs Price by Application (2021-2032)
  9. 12.3 SAMEA COX-2 Selective NSAIDs Market Size by Country
  10. 12.3.1 SAMEA COX-2 Selective NSAIDs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA COX-2 Selective NSAIDs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA COX-2 Selective NSAIDs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 COX-2 Selective NSAIDs Value Chain Analysis
  2. 13.1.1 COX-2 Selective NSAIDs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 COX-2 Selective NSAIDs Production Mode & Process
  6. 13.2 COX-2 Selective NSAIDs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 COX-2 Selective NSAIDs Distributors
  9. 13.2.3 COX-2 Selective NSAIDs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst